30日後の機能的能力と退院後の生存日数
消化器手術を受ける機能的能力が低いまたは良好な患者における30日後の生存日数と退院日数の評価
This prospective observational study aims to compare days alive and out of hospital at 30 days (DAOH-30) in patients with poor or good functional capacity undergoing gastrointestinal surgeries. The investigators are testing the hypothesis that patients with good functional capacity will have longer days alive and out of hospital than those with poor.
調査の概要
詳細な説明
Days Alive and Out of Hospital (DAOH) is a composite patient-centered outcome that integrates three critical clinical outcomes: death, hospital length of stay, and hospital readmission. It is associated with patient comorbidities, surgical complexity, and postoperative complications.
Evaluation of functional capacity before noncardiac surgery is recommended to identify the perioperative risks. Duke Activity Status Index (DASI) is one of the tools for determining functional capacity; the scores are between 0 and 58,2, and high scores are related to improved capacity. A DASI score of 34 and below was found to be a risk for moderate to severe complications and new disability.
The primary aim is to compare days alive and out of the hospital at 30 days in patients ≤ 34 and above 34 DASI scores. The secondary aims are to evaluate intensive care unit (ICU) need and duration, length of hospital stay, rehospitalization, postoperative complications, morbidity, and mortality in patients with DASI scores ≤ 34 and above 34. Days alive and out of hospital at 90 days will be compared in both groups as a secondary outcome. The investigators will also analyze the possible perioperative factors affecting the days alive and out of the hospital outcome.
Before the operation, the patients will answer the DASI questionnaire in the waiting area of the operating theatres. The patients will be divided into two groups according to the DASI score (Poor functional capacity: ≤ 34 points, good functional capacity: above 34 points).
Patient and surgical characteristics (comorbidities, American Society of Anesthesiologists physical status classification, laboratory values before the operation, frailty index value, American College of Surgeons Risk Calculator outcomes, surgery type, length of operation, intraoperative complications), ICU need and duration will be recorded. Postoperative complications ( cardiovascular, pulmonary, renal, neurologic, surgical, infectious, and wound ), the Postoperative Morbidity Survey (POMS) related morbidity and mortality on the 30th day will be investigated. Length of hospital stay starting with index surgery, rehospitalization and duration of further stays will be recorded. Days Alive and Out of Hospital at 30 days (DAOH-30) will be calculated using mortality, hospital length of stay, and readmissions between the date of the index surgery and the 30th postoperative day. 90th-day mortality and Days Alive and Out of Hospital at 90 days (DAOH-90) will also be investigated.
研究の種類
入学 (実際)
連絡先と場所
研究場所
-
-
Fatih
-
Istanbul、Fatih、トルコ(Türkiye)、34093
- Istanbul University Istanbul Medical Faculty, Department of Anesthesiology and Reanimation
-
-
参加基準
適格基準
就学可能な年齢
健康ボランティアの受け入れ
受講資格のある性別
サンプリング方法
調査対象母集団
Patients undergoing gastrointestinal surgeries at Istanbul Medical Faculty in Istanbul-Turkey will be selected for the study population. Istanbul Medical Faculty is a tertiary center university hospital with approximately 25.000 surgeries annually.
説明
Inclusion Criteria:
- Patients undergoing intermediate and major upper or lower gastrointestinal surgeries (small intestine, colon, rectal, gastric, esophagus) with a predicted hospital stay of more than 24 hours
- Patients aged 18 and above
- Signed written informed consent
- Reaching all perioperative data
Exclusion Criteria:
- Day case/ambulatory or one overnight hospital stay for minor gastrointestinal and perianal surgeries (hernia repair, hemorrhoidectomy, perianal abscess and fistula, appendectomy)
- Hepatobiliary surgeries (hepatectomy, pancreas and gallbladder surgeries)
- Patients aged below 18
- Not signed written informed consent
- Missing perioperative data
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 観測モデル:COHORT
- 時間の展望:PROSPECTIVE
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Group DASI ≤ 34
Patients with Duke Activity Status Index (DASI) scores are ≤ 34 before the surgery. |
All patients will answer the DASI questionnaire before surgery. According to their scores, they will be divided into two groups. A score of 34 and below will be considered poor, and above 34 will be considered to have good functional capacity. |
|
Group DASI > 34
Patients with Duke Activity Status Index (DASI) scores are > 34 before the surgery. |
All patients will answer the DASI questionnaire before surgery. According to their scores, they will be divided into two groups. A score of 34 and below will be considered poor, and above 34 will be considered to have good functional capacity. |
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Days alive and out of hospital at 30 days (DAOH-30)
時間枠:30 days
|
It is calculated using mortality, hospital length of stay, and readmissions between the date of the index surgery and the 30th postoperative day. |
30 days
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Days alive and out of hospital at 90 days (DAOH-90)
時間枠:90 days
|
It is calculated using mortality, hospital length of stay, and readmissions between the date of the index surgery and the 90th postoperative day. |
90 days
|
|
Postoperative complications
時間枠:30 days
|
Cardiovascular, pulmonary, renal, neurologic, surgical, infectious and wound complications |
30 days
|
|
The Postoperative Morbidity Survey (POMS) defined morbidity
時間枠:30 days
|
Pulmonary, infectious, renal, gastrointestinal, cardiovascular, neurological, hematological, wound complications and pain will be examined according to POMS |
30 days
|
|
Mortality
時間枠:30 days and 90 days
|
In and out of hospital mortality |
30 days and 90 days
|
|
Intensive care unit (ICU) stay
時間枠:30 days
|
Duration of ICU stay (days) |
30 days
|
|
Length of hospital stay after index surgery
時間枠:30 days
|
Length of first hospital stay starting with index surgery (days) |
30 days
|
|
Rehospitalization
時間枠:30 days and 90 days
|
Readmission and hospitalization after first discharge |
30 days and 90 days
|
協力者と研究者
スポンサー
捜査官
- 主任研究者:Muserref B Dincer、Istanbul University, Istanbul Medical Faculty, Department Anesthesiology and Reanimation
研究記録日
主要日程の研究
研究開始 (実際)
一次修了 (実際)
研究の完了 (実際)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 2024/178
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。